期刊文献+

人血管内皮抑素毕赤酵母真核系统的建立

Construction of Human Endostatin in Yeast Eukaryotic Expression Vector
下载PDF
导出
摘要 目的构建人血管内皮抑素(ES)毕赤酵母真核表达系统。方法利用RT-PCR技术从人体肝脏组织扩增出ES基因,插入毕赤酵母表达载体pPIC9中,酶切鉴定并进行DNA测序鉴定。结果成功克隆ES基因并筛选出pPIC9载体中的ES阳性克隆,测序证实其序列与已报道的ES基因序列一致。结论用分子生物学方法构建ES毕赤酵母真核表达载体的成功,使高效表达ES蛋白成为可能,并为采用抗血管生成方法治疗恶性肿瘤的研究奠定了基础。 Objective To construct yeast eukaryotic expression vector carrying human endostatin (ES) cDNA. Methods The functional fragment of endostatin gene in human hepatic tissue was amplified by using RT- PCR technology, and cloned into yeast pPIC9 expression vector. The positive clone was sequenced by using automatized sequencer. Results The endostatin cDNA was successfully cloned. The positive ES clone gene in pPIC9 expression vector was sieved, and its coding sequence was identified to be as same as the previously reported sequence. Conclusion The successful construction of ES gene in pPIC9 expression vector using molecular biological method maybe helpful for the high expression of ES protein, which may lay the foundation for the treatment of malignant tumor through anti-angiogenesis appoach.
出处 《中国普外基础与临床杂志》 CAS 2007年第4期417-419,共3页 Chinese Journal of Bases and Clinics In General Surgery
基金 山东省卫生厅科研基金资助(编号:2005-36)
关键词 人血管内皮抑素 克隆 构建 酵母 Human endostatin Clone Construction Yeast
  • 相关文献

参考文献11

  • 1O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997; 88(2):277
  • 2Davis DW,Shen Y,Mullani NA,et al.Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors[J].Clin Cancer Res,2004; 10(1 Pt 1):33
  • 3Capillo M,Mancuso P,Gobbi A,et al.Continuous infusion of endostatin inhibits differentiation,mobilization,and clonogenic potential of endothelial cell progenitors[J].Clin Cancer Res,2003; 9(1):377
  • 4贺祥,潘卫,芮耀诚,戚中田.血管生成抑制素Endostatin研究新进展[J].中国肿瘤生物治疗杂志,2000,7(1):76-78. 被引量:16
  • 5杨林,王金万,汤仲明,刘秀文,黄镜,李树婷,董英,张和平,薛岚,储大同,孙燕.重组人血管内皮抑制素Ⅰ期临床研究[J].中国新药杂志,2004,13(6):548-553. 被引量:154
  • 6Boehm T,Folkman J,Browder T,et al.Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J].Nature,1997; 390(6658):404
  • 7Nyberg P,Heikkila P,Sorsa T,et al.Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2,-9,and -13[J].J Biol Chem,2003; 278(25):22404
  • 8邵俊伟,刘然义,易继林,卢绮萍,黄文林.内皮抑素转基因治疗裸鼠人肝癌的实验研究[J].中国普外基础与临床杂志,2006,13(2):145-149. 被引量:1
  • 9Hansma AH,Broxterman HJ,van der Horst I,et al.Recombinant human endostatin administered as a 28-day continuous intravenous infusion,followed by daily subcutaneous injections:a phase Ⅰ and pharmacokinetic study in patients with advanced cancer[J].Ann Oncol,2005; 16(10):1695
  • 10Minning S,Serrano A,Ferrer P,et al.Optimization of the high-level production of Rhizopus oryzae lipase in Pichia pastoris[J].J Biotechnol,2001; 86(1):59

二级参考文献18

  • 1[3]O'Reilly MS,Boehm T,Shing Y,et al. Endostatin:An endogenous inhibitor of angiogenesis and tumour growth [ J ]. Cell,1997,88(1) :277 - 285.
  • 2[4]Eder JP, Supko JG, Clark JW, et al. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily[ J ]. J Clin Oncol, 2002,20 (18): 3772 -3784.
  • 3[5]Gehan EA, Teffe MC. Will there be resistance to the RECIST (Response Evaluation Criteria In Solid Tumors)? [J]. J Natl Cancer Inst ,2000,92(3): 179 - 181.
  • 4[6]Yoon SS, Eto H, Lin CM, et al. Mouse endostatin inhibits the formation of lung and liver metastases[ J ]. Cancer Res, 1999,59(24): 6251 - 6256.Chinese Journal of New Drugs 2004,Vol. 13 No. 6
  • 5[7]Yokoyama Y, Dhanabal M, Griffioen AW, et al. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth[J]. Cancer Res ,2000,60(8) :2190 - 2196.
  • 6[8]Sim BKL,Fogler WE,Zhou XH, et al. Zinc ligand-disrupted recombinant human endostatin: Potent inhibitions of tumor growth, safety and pharmacokinetic profile [ J ]. Angiogenesis,1999,3(1) :41 - 51.
  • 7[9]Herbst RS,Hess KR,Tran HT, et al. Phase I study of recombinant human endostatin in patients with advanced solid tumors[ J ]. J Clin Onco, 2002,20 (18): 3792 - 3803.
  • 8[10]Thomas JP,Arzoomanian RZ,Alberti D, et al. Phase Ⅰ pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors[J]. J Clin Onco,2003,21 (2): 223 - 231.
  • 9[1]Sim BK, MacDonald NJ, Gubish ER. Angiostatin and endostatin:Endogenous inhibitors of tumour growth[J]. Cancer Metastasis Rev ,2000,19(1 - 2): 181 - 190.
  • 10[2]Zatterstrom UK, Felbor U, Fukai N, et al. Collagen XVⅢ / endostatin structure and functional role in angiogenesis [ J ]. Cell Struct Funct ,2000,25(1): 97 - 101.

共引文献168

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部